HSIC

Q: What is the price of Henry Schein (HSIC) today?

A cotação de Henry Schein (HSIC) hoje está em $ 69.45, com uma variação de The stock began the year trading around $ 75.58 and is currently priced at $ 69.45. negociando na casa dos $ 75.58 e hoje está em $ 69.45. Acompanhe o and track broader market trends directly on the platform.

Q: When does Henry Schein (HSIC) pay dividends?

Henry Schein (HSIC) did not pay dividends over the past year.

Q: Is Henry Schein (HSIC) a good investment?

Atualmente, Henry Schein (HSIC) está cotada a $ 69.45, com um P/L de 20.62, This represents a 2,185% premium compared to its historical average P/E. uma variação de -1.55 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -1.55%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Henry Schein Inc.

Price

$ 69.45

return (12m)

-1.55%

p/e

20.62

p/bv

1.69

DIVIDEND YIELD

0.00%

HSIC price

HSIC

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment HSIC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-8.61%

3 months

-11.45%

1 year

-1.55%

2 years

-5.03%

5 years

-13.73%

10 years

-20.19%

Fundamentals HSIC

review the fundamentals of Henry Schein shares

P/E

20.62

Sector: -1.72 Industry: -6.35

P/S (PSR)

0.61

Sector: 1.94 Industry: 2.91

P/BV

1.69

Sector: 2.16 Industry: 2.13

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

3.49%

Sector: -25.77% Industry: -48.73%

ROE

8.19%

Sector: -29.19% Industry: -40.71%

ROIC

6.53%

Sector: -428.36% Industry: -515.65%

NET MARGIN

2.95%

Sector: -27.84% Industry: -31.71%

GROSS MARGIN

31.19%

Sector: 45.02% Industry: 45.02%

OPERATING MARGIN

5.62%

Sector: -22.92% Industry: -27.64%

EV/EBITDA

8.16

Sector: -0.31 Industry: -2.65

EV/EBIT

11.77

Sector: -1.90 Industry: -5.73

PRICE-TO-ASSETS

0.72

Sector: 1.16 Industry: 1.35

BVPS

41.93

Sector: 3.78 Industry: 2.13

EPS

3.43

Sector: -0.82 Industry: -1.28

EQUITY-TO-ASSETS RATIO

0.43

Sector: 0.43 Industry: 0.49

LIABILITIES / ASSETS

0.57

Sector: 0.47 Industry: 0.43

CAGR REVENUE 5 YEARS

1.54%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-8.95%

Sector: - Industry: -

FAIR VALUE OF Henry Schein ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 69.45

Fair Value

$ 0.00

Upside/Downside Return potential.

-18.09%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals HSIC

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	33.59	27.21	81.01%	0.66%	$ 848.86 B	34.98%
ISRG	53.63	9.08	16.93%	0.00%	$ 159.77 B	28.15%
TMO	25.26	3.32	13.15%	0.38%	$ 172.98 B	15.15%
SNY	11.59	1.26	10.86%	5.11%	$ 105.72 B	18.68%
NVS	20.60	7.16	34.77%	2.12%	$ 278.77 B	23.92%
ABT	25.14	0.00	0.00%	2.64%	$ 157.79 B	13.91%
MDT	21.18	1.99	9.38%	3.73%	$ 97.70 B	13.00%
GSK	12.93	4.37	33.77%	3.48%	$ 101.42 B	17.79%
CVS	39.31	1.48	3.78%	2.94%	$ 115.27 B	0.72%
BSX	22.46	0.00	0.00%	0.00%	$ 80.09 B	17.29%
TMDX	13.42	4.67	34.80%	0.00%	$ 2.31 B	27.04%
HCA	14.35	-32.73	-228.14%	0.68%	$ 97.48 B	8.89%
IDXX	40.91	28.80	70.38%	0.00%	$ 44.81 B	24.63%
RMD	19.73	4.62	23.41%	1.13%	$ 29.98 B	27.44%
DHR	32.85	2.29	6.97%	0.79%	$ 121.18 B	14.89%
INMD	10.09	1.33	13.18%	0.00%	$ 879.48 M	23.27%
PHG	22.93	1.96	8.56%	3.26%	$ 25.90 B	5.50%
SYK	32.76	4.76	14.52%	1.21%	$ 109.34 B	13.21%
FMS	11.00	0.74	6.71%	3.57%	$ 12.12 B	4.89%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

HSIC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Henry Schein

Henry Schein Inc.

Average Investor10 user rating

4.0 (4 people)

United States

34 years

Founded: 1992

1995

Time since IPO - 31 years

19.000

Employees

Henry Schein Inc. (United States) is listed on the Nasdaq and has a market capitalization of $8.14 Billions, with shareholders equity totaling $4.82 Billions.

The company employs approximately 19.000 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Henry Schein Inc. reported $13.38 Billions in revenue, generating net income of $395.00 Millions.

Key financial metrics include a P/E ratio of 20.62, a price-to-book (P/B) ratio of 1.69, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker HSIC.

Market cap

$ 8.14 Billions

Net worth

$ 4.82 Billions

$ 4,822,000,000.00

Assets

$ 11.30 Billions

$ 11,304,000,000.00

Total Shares Outstanding

115.00 Millions

115,000,000

Average Daily Trading Volume

$ 1.28 Million

$ 1,284,038.30

Sector

Health

Industry

Medical Supplies and Equipment

HSIC

HSIC revenue and profits

Financial Results HSIC

DRAG THE FRAME TO SEE MORE DATA

HSIC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 98.11 69,38% (12M)

P/E

39.31

2.94%

ROE

3.78%

P/BV

1.48

CI - Cigna

$ 300.71 1,78% (12M)

P/E

10.52

2.11%

ROE

16.97%

P/BV

1.79

CNC - Centene

$ 58.81 --1,11% (12M)

P/E

-4.27

0.00%

ROE

-29.93%

P/BV

1.28

HUM - Humana

$ 304.85 34,80% (12M)

P/E

29.20

1.29%

ROE

6.06%

P/BV

1.77

LLY - Eli Lilly

$ 1,015.75 39,78% (12M)

P/E

33.59

0.66%

ROE

81.01%

P/BV

27.21

HCA - HCA Healthcare

$ 427.54 17,33% (12M)

P/E

14.35

0.68%

ROE

-228.14%

P/BV

-32.73

NVS - Novartis

$ 149.72 45,40% (12M)

P/E

20.60

2.12%

ROE

34.77%

P/BV

7.16